Form 4 for DVA DaVita
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0000927066-24-000194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | DVA | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +37.4K | 875.3K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | A | A | 37,423 | $0.00 | 875,258 | D | — | — | (F1) These restricted stock units are scheduled to vest 33.333% each on November 15, 2025, November 15, 2026 and November 15, 2027, subject to continued service through each applicable vesting date. |